Nuvation Bio (NUVB) financials · rev $62.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Nuvation Bio (NUVB) rev $62.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $62.9M | $7.87M |
| Cost of Revenue | N/A | $7.08M |
| Gross Profit | N/A | $795.0K |
| Operating Income | -$213.1M | -$592.6M |
| Net Income | -$204.6M | -$567.9M |
| EPS (Diluted) | -$0.60 | -$2.11 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $594.8M | $540.6M |
| Current Assets | $571.5M | $526.3M |
| Cash & Equivalents | $164.1M | $35.7M |
| Inventory | $11.4M | $0 |
| PP&E | $564.0K | $586.0K |
| Total Liabilities | $289.1M | $76.8M |
| Current Liabilities | $82.2M | $58.2M |
| Short-term Debt | $5.72M | $6.28M |
| Long-term Debt | $47.2M | N/A |
| Total Debt | $52.9M† | $6.28M† |
| Shareholders' Equity | $305.7M | $463.8M |
| Retained Earnings | -$1.12B | -$910.7M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$173.4M | -$130.4M |
| CapEx | $8.00M | N/A |
| Investing Cash Flow | $99.5M | $122.7M |
| Financing Cash Flow | $202.5M | $331.0K |
| Net Change in Cash | $128.4M | -$6.93M |
| Free Cash Flow | -$181.4M | -$130.4M |
FAQ
What is NUVB P/E and revenue?
Nuvation Bio (NUVB) rev $62.9M.
What is NUVB revenue?
Nuvation Bio last cached revenue is $62.9M (FY2025).
Is NUVB profitable?
Nuvation Bio last cached net income is -$204.6M (FY2025).
What are NUVB total assets?
Nuvation Bio last cached total assets are $594.8M (FY2025).
What is NUVB free cash flow?
Nuvation Bio last cached free cash flow is -$181.4M (FY2025).
Not investment advice. Cached statements, not a live tape.